At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Switching to a Vaping Device: Evaluating Risk Reduction Among Quitline Treatment Failure
In Brief
A clinical study evaluating JUUL and Treatment As Usual for Smoking, Cigarette. Completed, enrolled 350 participants across 1 site.
Detailed Summary
The overall aim of the study is to evaluate the provision of e-cigarette (EC) versus NRT on smoking behavior, product use patterns and continued use, and iCO, a biomarker of toxicant exposure, among a sample of recent QL treatment failures. We will randomly assign N=372 smokers (targeted accrual) to EC (n=186) or QL treatment as usual with combination nicotine replacement therapy (NRT; n=186). All participants will receive three calls from QL coaches and EC and NRT will be provided at no cost for 8 weeks. The final follow-up will occur 12-weeks post baseline.
Study Details
Timeline
Interventions
Participants randomized to the JUUL group will receive either tobacco or menthol flavored JUUL with 5% nicotine. Will also receive counseling.
Nicotine Replacement Therapy consisting of nicotine patches and lozenge along with standard quitline counseling.